The U.S. Food and Drug Administration has approved the antiretroviral drug Truvada, to be used as a preexposure preventive measure by people who, uninfected, may be exposed to the virus through HIV-positive partners. The drug previously was approved to treat people living with HIV. As a preventive measure the drug would be taken daily, by […]
Justice in Prisons: Health Access, Treatment and Prevention at Prisoner Networking Zone Often coming from situations of the greatest risks for HIV, the dangers confronting prisoners are multiplied when, in overcrowded cells, lacking basic nutrition, health and hygiene and ability to protect themselves from infection, they are locked away, whether convicted or awaiting trial in […]
HIV
From 2016 to 2017, 14% of people living with HIV in the United States did something to save money on the out-of-pocket costs of their prescription […]
Tuberculosis
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would […]
Research & Development
This year marks the close of a dynamic decade in global infectious disease research and responses that changed expectations of what humanity can accomplish toward making […]
Policy
Wuhan City in the Hubei Province of the People’s Republic of China is on the Yangtze River and is the most populous city in central China. […]